Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo

Fig. 1

The cost of an active screening strategy. The cost of active screening for a coverage of 55%, a screening interval of 1 year, stopping active screening after 3 screenings when no cases are detected and stopping reactive screening after 1 screening with no cases, under the assumption of WTPc=0.5. Mean values for all quantities are taken from one million stochastic simulations. a The number of infected people dramatically decreases with time for this coverage (total shaded blue area, with left axis) with the majority of these infections being in the high-risk group (darker blue fraction). The proportion of tsetse that are also infective is reduced with time (green line, with right axis). b The total change in costs of implementing a particular screening strategy (left axis) and the number of DALYs averted from the baseline of only passive surveillance (right axis). c The contribution to the cost from each component of the cost function for years 1, 5, 10, 20 and 30 after starting an active screening programme. Full costs are given in the table in the bottom row of the table. A population size of NH=1,000 is used. All costs are denominated in 2018 US dollars

Back to article page